This is a routine non-C-suite departure with standard severance. No material impact on operations or stock. Monitor the next periodic report for the full separation agreement and any successor appointment.
Price Chart
Executive Summary
Nexalin Technology disclosed the departure of Carolyn Shelton, Senior Vice President of Quality, Regulatory, and Clinical Affairs, effective August 28, 2026. The departure is a routine senior VP exit with a standard separation agreement including one month of base salary, a $20,000 bonus, and accelerated option vesting. No replacement is named, but this is a non-C-suite role and the terms suggest an amicable separation, making the event low-impact and neutral for the stock.
Key Facts
- Carolyn Shelton departed as Senior VP of Quality, Regulatory, and Clinical Affairs on August 28, 2026.
- Separation agreement includes one month of continued base salary, a $20,000 bonus, accelerated vesting of unvested stock options, and health insurance subsidy through September 30, 2026.
- No replacement was named in the filing.
- The departure is not a CEO/CFO exit and the language used ('departed') with standard severance suggests no red flags.
Financial Impact
Separation costs limited to one month salary, $20,000 bonus, and option acceleration — immaterial for a $6M market cap company.
Risk Factors
- Potential loss of regulatory/clinical expertise if not replaced promptly
- No successor named could signal difficulty attracting talent at a micro-cap
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001829126-26-009659 |
| Document: 0001829126-26-009659-index-headers.html | 0001829126-26-009659 |
| Document: 0001829126-26-009659-index.html | 0001829126-26-009659 |
| Document: 0001829126-26-009659.txt | 0001829126-26-009659 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 11d ago | EFFECT | $2.35 | awaiting T+20 | — | $1.64 (+30.21%) |
Oct 8, 2026 19d ago | S-1/A | $3.63 | awaiting T+20 | — | $1.64 (+54.82%) |
Oct 1, 2026 26d ago | 8-K | $5.73 | awaiting T+20 | — | $1.64 (−71.38%) |
Oct 1, 2026 26d ago | 8-K | $5.73 | awaiting T+20 | — | $1.64 (−71.38%) |
Sep 2, 2026 7w ago | 8-K | $5.36 $4.28 | ▼ −20.15% | ▼ −19.03% | $1.64 (−69.40%) |
Aug 27, 2026 8w ago | 8-K | $0.2548 $0.1463 | ▼ −42.57% | ▼ −42.60% | $1.64 (+543.64%) |
Aug 17, 2026 10w ago | 8-K | $0.3400 $0.1617 | ▲ +52.45% | ▲ +50.47% | $1.64 (−382.35%) |
Jun 10, 2026 19w ago | Press Release | $0.4590 $0.4607 | ▲ +0.37% | ▼ −3.70% | $1.64 (+257.30%) |
May 19, 2026 23w ago | 8-K | $0.3350 $0.3680 | ▲ +9.85% | ▲ +9.11% | $1.64 (+389.55%) |
May 19, 2026 23w ago | Press Release | $0.3210 $0.3930 | ▲ +22.43% | ▲ +21.44% | $1.64 (+410.90%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers